INMB

Conviction 59HealthcareScan · Thu, Jun 25, 2026

Bullish engulfing

INMB$1.50+11.11%

ResistanceSupportVol 14

Vol MA14 504.47K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Inmune Bio, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.inmunebio.com ↗

Price1.50

Change+11.11%

Gap+0.00%

Rel volume11.29×

Avg volume475.5K

Avg $ vol668.23K

SMA 201.34

SMA 501.40

SMA 2001.57

Price vs 50+7.25%

Price vs 200-4.35%

MA stackmixed

50/200 cross—

Supertrenddown · 1.50

RSI (14)60

MACD hist0.02

MACD crossbull · 4d

Stoch %K / %D79 / 65

ADX (14)19

+DI / −DI23 / 10

RSI divergence—

MACD divergence—

ATR %+7.59%

ADR %7.61%

52w high7.37

52w low1.12

From 52w high-79.65%

Above 52w low+33.93%

New 52w highNo

SqueezeOff

Bollinger width25.40%

%B0.98

Donchian pos78.95%

Donchian high1.58

Donchian low1.20

AVWAP (52w high)3.20

vs AVWAP high-53.18%

AVWAP (52w low)1.43

vs AVWAP low+4.66%

OBV trendUp

Chaikin MF (20)-0.01

Today vs 20d11.29×

Avg vol (14d)504.47K

Avg vol (20d)475.5K

Avg $ vol (20d)668.23K

Market cap39.88M

RS 3m (vs SPY)+2.15%

RS 6m (vs SPY)-33.97%

RS line new highNo

Trend template3/8

Technical rank48.9

1 week+15.38%

1 month+4.90%

3 months+22.95%

6 months-20.21%

1 year-77.31%

YTD-2.60%

P/E-0.87

P/B2.03

P/S797.56

P/FCF-1.69

EPS-1.86

Div yield—

ROE-234.07%

ROA-177.91%

Debt/Eq0.62

Current4.24

EV/EBITDA—

Gross margin—

Net margin—

Rev growth257.14%

EPS growth-9.15%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value27.32M

Revenue50K

Net income-5.41M

Gross profit—

Free cash flow-23.62M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out26.59M

Employees21

ListedMon, Feb 4, 2019

Free float22.06M

Float %83.0%

Short interest3.69M

Days to cover14.4d

Short volume45.4%

Squeeze score77 / 100

Next earningsThu, Aug 6, 2026 (42d)

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction59 / 100

Pattern quality—

Tech rank48.9 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish engulfing

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in INMB

All disclosures →

No recent disclosed trades by Congress in INMB. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in INMB

No recent insider (Form 4) filings in INMB. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in INMB · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.